Gyre Therapeutics Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Gyre Therapeutics Inc inventory turnover ratio, the Gyre Therapeutics Inc 's ability to sell and replace its inventory in the second quarter 2026, sequentially increased to 0.65 in the second quarter 2026, GYRE's markets remain strong, its supply chain continue to be in a grate shape.Average inventory processing period, for the Gyre Therapeutics Inc in Jun 30 2026 quarter, has decreased to 562 days, compare to 619 days, in the Mar 31 2026 quarter.

Within Healthcare sector 342 other companies have achieved higher inventory turnover ratio. While in terms of ranking among all other companies, the company has moved form 1590 in the first quarter 2026, to 1878.

GYRE Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Gyre Therapeutics Inc Market Share?

What is Inventory Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Inventory Turnover▼

None ▼

Inventory Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

GYRE Inventory Turnover Ratio	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter
Y / Y Inventory Growth	28.97 %	44.1 %	60.5 %	38.8 %	57.25 %
Y / Y Cost of Sales Growth	91.92 %	37.25 %	48.09 %	69.94 %	49.48 %
Inventory Turnover Ratio (TTM)	0.65	0.59	0.61	0.61	0.57
GYRE's Total Ranking	# 1878	# 1590	# 1434	# 1189	# 1615
Average inventory processing period	560	623	603	601	643
Seq. Inventory Growth	0.67 %	11.61 %	14.87 %	-0.08 %	12.48 %
Seq. Cost of Sales Growth	80.03 %	-29.6 %	7.06 %	41.44 %	28.75 %

Inventory Turnover Ratio Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 105
Healthcare Sector	# 343
Overall Market	# 1878

Inventory Turnover Ratio Statistics
High	Average	Low
0.75	0.63	0.57
(Sep 30 2024)		(Jun 30 2025)

GYRE Company Profile >> Back to GYRE Efficiency Comparisons >> Compare GYRE Inventory Turnover Ratio to its Competitors

Financial Statements
Gyre Therapeutics Inc 's Inventories	$ 11 Millions	Visit GYRE's Balance sheet
Gyre Therapeutics Inc 's Cost of Revenues TTM	$ 7 Millions	Visit GYRE's Income Statement
What are GYRE's Sales?		Visit GYRE's Sales by Segment

Other Inventory Turnover Ratios
Gyre Therapeutics Inc 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Major Pharmaceutical Preparations Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
GYRE's Inventory Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for GYRE's Competitors
Inventory Turnover Ratio for GYRE's Suppliers
Inventory Turnover Ratio for GYRE's Customers

You may also want to know
GYRE's Sales Growth Rates	GYRE's Pe Price to earnings ratio	GYRE's Receivables Turnover Ratio	GYRE's Stock Quote
GYRE's Net Income Growth Rates	GYRE's Ps Price to Sales ratio	GYRE's Sales per Employee	GYRE's Asset Turnover Ratio
GYRE's Net Margin	GYRE's Pb Price to Book ratio	GYRE's Financial Strength Ratios	GYRE's Dividend Payout Ratio

Companies with similar Inventory Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector	Inventory Turnover Ratio	Cost of revenues at quarter ending Jun 30 2026	Inventories at quarter ending Jun 30 2026
Sanuwave Health Inc	1.62	$ 10.421 Millions	$ 6 Millions
Bio rad Laboratories Inc	1.62	$ 1,245.200 Millions	$ 769 Millions
Innovative Eyewear Inc	1.61	$ 2.634 Millions	$ 2 Millions
Pfizer Inc	1.60	$ 17,084.000 Millions	$ 10,684 Millions
Capsovision Inc	1.60	$ 5.736 Millions	$ 4 Millions
Integra Lifesciences Holdings Corp	1.59	$ 783.084 Millions	$ 492 Millions
Ss Innovations International Inc	1.58	$ 28.689 Millions	$ 18 Millions
Rapid Micro Biosystems Inc	1.57	$ 29.477 Millions	$ 19 Millions
Bausch and Lomb Corp	1.54	$ 1,523.000 Millions	$ 989 Millions
Staar Surgical Co	1.53	$ 79.388 Millions	$ 52 Millions
Abeona Therapeutics Inc	1.51	$ 8.405 Millions	$ 6 Millions
Axogen inc	1.45	$ 63.909 Millions	$ 44 Millions
Cv Sciences Inc	1.45	$ 5.804 Millions	$ 4 Millions
Nuwellis Inc	1.43	$ 2.732 Millions	$ 2 Millions
Cormedix Inc	1.42	$ 45.432 Millions	$ 32 Millions
Cumberland Pharmaceuticals Inc	1.41	$ 5.164 Millions	$ 4 Millions
Standard Biotools Inc	1.41	$ 28.569 Millions	$ 20 Millions
Biocorrx Inc	1.40	$ 0.170 Millions	$ 0 Millions
Lensar Inc	1.38	$ 31.126 Millions	$ 23 Millions
Alphatec Holdings Inc	1.32	$ 237.415 Millions	$ 179 Millions
Tenet Healthcare Corp	1.32	$ 453.000 Millions	$ 344 Millions
Xtant Medical Holdings Inc	1.28	$ 43.701 Millions	$ 34 Millions
Edwards Lifesciences Corporation	1.28	$ 1,443.400 Millions	$ 1,129 Millions
Globus Medical Inc	1.27	$ 989.145 Millions	$ 779 Millions
Karyopharm Therapeutics Inc	1.27	$ 4.942 Millions	$ 4 Millions
Clene Inc	1.25	$ 0.059 Millions	$ 0 Millions
Kyntra Bio Inc	1.24	$ 4.444 Millions	$ 4 Millions
Pulmonx Corporation	1.24	$ 20.014 Millions	$ 16 Millions
Biolife Solutions Inc	1.24	$ 39.035 Millions	$ 32 Millions
Stereotaxis Inc	1.23	$ 13.184 Millions	$ 11 Millions

Date modified: 2026-08-14T20:17:45+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.